KALA BIO
KALA----
KALA BIO (KALA)
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
KALA BIO Analyst Rating
View MoreForecast & Rating
Oct 29, 2025Price forecast
$75.0010244.83%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 14 at 06:47 AM
Unbundling the Value Chain: Business Models from Digital Infrastructure to Physical Scale
- Global Report · Jul 8 at 10:32 PM
Capital Reallocation and Physical Constraints: The Barbell Market of 2026
- Price Alert · Jul 1 at 05:37 AM
Pre-market hot trades in US stocks: Kala Bio up 9.83% in pre-market, active funds but no positive news
- Price Alert · Jun 18 at 11:27 AM
U.S. stock market midday update: KALA BIO rises 20.21%, gene-editing ophthalmic therapy in demand
- Global Report · Jun 18 at 07:46 AM
Rebundling the Tech Stack: How Hardware and AI Reshape the Value Chain
- TradingView · May 15 at 02:41 PM
KALA BIO, Inc. 1Q 2026: Net loss $(1.6M), Diluted EPS $(0.14) — 10-Q Summary
